ARKAY:OTC-Arkema S.A (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 121.61

Change

+1.62 (+1.35)%

Market Cap

USD 8.87B

Volume

3.81K

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Arkema S.A (ARKAY) Stock Analysis:
Based on the Arkema S.A stock forecasts from 0 analysts, the average analyst target price for Arkema S.A is not available over the next 12 months. Arkema S.A’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Arkema S.A is Slightly Bullish , which is based on 5 positive signals and 3 negative signals. At the last closing, Arkema S.A’s stock price was USD 121.61. Arkema S.A’s stock price has changed by +3.09% over the past week, +4.13% over the past month and -7.22% over the last year.

No recent analyst target price found for Arkema S.A
No recent average analyst rating found for Arkema S.A

About

Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It provides adhesive solutions for construction, renovation of buildings, D ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-16 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AIQUY L'Air Liquide S.A

+0.21 (+0.63%)

USD78.42B 29.05 14.94
SKFOF Sika AG

-0.65 (-0.24%)

USD39.10B 40.27 22.64
SXYAY Sika AG

-0.32 (-1.20%)

USD38.07B 39.56 22.64
GVDBF Givaudan SA

N/A

USD33.66B 41.14 25.58
GVDNY Givaudan SA

+0.36 (+0.50%)

USD33.09B 40.08 25.58
KDSKF Koninklijke DSM N.V

-1.20 (-0.81%)

USD25.51B 14.53 15.86
RDSMY Koninklijke DSM N.V

-0.24 (-0.65%)

USD25.38B 14.44 15.86
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD21.28B 38.79 27.27
NPCPF Nippon Paint Holdings Co. Ltd

N/A

USD18.56B 34.81 0.16
NVZMF Novozymes A/S

N/A

USD17.36B 39.31 4.16

ETFs Containing ARKAY

Symbol Name Weight Mer Price(Change) Market Cap
FTEU:LSE First Trust Global Funds .. 0.00 % 0.80 %

+0.16 (+0.46%)

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.21% 64% D 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.21% 59% F 48% F
Trailing 12 Months  
Capital Gain -5.74% 79% C+ 68% D+
Dividend Return 2.33% 56% F 31% F
Total Return -3.41% 72% C- 66% D
Trailing 5 Years  
Capital Gain 14.03% 65% D 63% D
Dividend Return 12.43% 70% C- 43% F
Total Return 26.46% 64% D 63% D
Average Annual (5 Year Horizon)  
Capital Gain 5.10% 36% F 40% F
Dividend Return 2.59% 63% D 55% F
Total Return 7.69% 50% F 41% F
Risk Return Profile  
Volatility (Standard Deviation) 25.89% 72% C- 73% C
Risk Adjusted Return 29.70% 52% F 53% F
Market Capitalization 8.87B 74% C 88% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 6.70 84% B 72% C-
Price/Book Ratio 1.21 73% C 57% F
Price / Cash Flow Ratio 9.70 34% F 17% F
EV/EBITDA 3.83 67% D+ 50% F
Management Effectiveness  
Return on Equity 22.56% 86% B 87% B+
Return on Invested Capital 8.93% 54% F 67% D+
Return on Assets 5.93% 72% C- 84% B
Debt to Equity Ratio 40.65% 49% F 40% F
Technical Ratios  
Dividend Yield 2.72% 53% F 37% F
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.27 25% F 33% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector